Cesium carbonate → HCID 86004373, compound
Reaction equation
[N:1]1[O:5][N:4]=[C:3]2[CH:6]=[C:7]([C:10]3[CH:11]=[C:12]([OH:16])[CH:13]=[CH:14][CH:15]=3)[CH:8]=[CH:9][C:2]=12.C(=O)([O-])[O-].[Cs+].[Cs+].Br[CH2:24][CH2:25][F:26]>CN(C=O)C>[F:26][CH2:25][CH2:24][O:16][C:12]1[CH:11]=[C:10]([C:7]2[CH:8]=[CH:9][C:2]3[C:3]([CH:6]=2)=[N:4][O:5][N:1]=3)[CH:15]=[CH:14][CH:13]=1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
600 mg (2.83 mmol) 3-benzo[1,2,5]oxadiazol-5-yl-phenol are dissolved in 15 mL DMF and stirred for 20 hours at room temperature in the presence of 1.15 g (1.25 eq.) cesium carbonate and 0.264 mL 1-bromo-2-fluoroethane. The reaction mixture is extracted with water and ethyl acetate, the combined organic phases are washed with water and brine, dried with magnesium sulfate and evaporated to dryness. The residue is column chromatographed (gradient from hexane to hexane/ethyl acetate 3:2) to yield the desired product as a pale yellow powder. MS(ES+): 259 (M+1).
Workup
- extractionThe reaction mixture is extracted with water and ethyl acetate
- washthe combined organic phases are washed with water and brine
- dry with materialdried with magnesium sulfate
- customevaporated to dryness
- customchromatographed (gradient from hexane to hexane/ethyl acetate 3:2)
Sources & evidence
- ORD record
- ord-705ff33980d84ca6a47fe84539415e06
- Source dataset
- uspto-grants-2009_12
- Patent number
- US07632851B2
Reaction notes
Loading…